Clinical Trials - July 14, 2026
Evaxion presents new preclinical data for cytomegalovirus vaccine program
Evaxion has presented new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1.
Agreement - July 14, 2026
Prolight signs development agreement with BRAINBox
Prolight Diagnostics has announces the successful completion of a 260-patient feasibility study and the subsequent signing of a development agreement with BRAINBox Solutions.
Biotech article - July 13, 2026
New clinical data on the Leqembi subcutaneous autoinjector presented
BioArctic's partner Eisai has presented new data at the 2026 Alzheimer’s Association International Conference (AAIC), held in London, July 12-15, demonstrating that the Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) formulation offers efficacy and safety comparable to intravenous (IV) administration in people with early Alzheimer’s disease.
Science News - July 13, 2026
First in-human clinical trial results for Parkinson’s disease cell therapy
A landmark study led from Lund University has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects directly linked to the transplanted cells were seen during the first year of follow up.
Biotech Business - July 10, 2026
Biovica refocuses US strategy and terminates agreement with Tempus AI
Biovica has, by mutual agreement, ended the reference laboratory agreement with Tempus AI, announced in May 2025.
Science News - July 8, 2026
Antibodies in the nose may protect against influenza infection
High levels of influenza-specific IgA antibodies in the nasal mucosa are linked to a reduced risk of infection, according to a new study from Danderyd Hospital and SciLifeLab.
